Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W David Church

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
SLAS Discovery : Advancing Life Sciences R & D|December 20, 2019
Forced Self-Modification Assays as a Strategy to Screen MonoPARP EnzymesTim J Wigle, W David Church, Christina R Majer, et al.
Cell Chemical Biology|July 18, 2020
In Vitro and Cellular Probes to Study PARP Enzyme Target EngagementTim J Wigle, Danielle J Blackwell, Laurie B Schenkel, et al.
Chembiochem : a European Journal of Chemical Biology|April 10, 2021
Targeted Degradation of PARP14 Using a Heterobifunctional Small MoleculeTim J Wigle, Yue Ren, Jennifer R Molina, et al.
Cell Chemical Biology|March 11, 2021
A potent and selective PARP14 inhibitor decreases protumor macrophage gene expression and elicits inflammatory responses in tumor explantsLaurie B Schenkel, Jennifer R Molina, Kerren K Swinger, et al.
Cancer Cell|August 10, 2021
PARP7 negatively regulates the type I interferon response in cancer cells and its inhibition triggers antitumor immunityJoseph M Gozgit, Melissa M Vasbinder, Ryan P Abo, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
SLAS Discovery : Advancing Life Sciences R & D|December 20, 2019
Forced Self-Modification Assays as a Strategy to Screen MonoPARP EnzymesTim J Wigle, W David Church, Christina R Majer, et al.
Cell Chemical Biology|July 18, 2020
In Vitro and Cellular Probes to Study PARP Enzyme Target EngagementTim J Wigle, Danielle J Blackwell, Laurie B Schenkel, et al.
Chembiochem : a European Journal of Chemical Biology|April 10, 2021
Targeted Degradation of PARP14 Using a Heterobifunctional Small MoleculeTim J Wigle, Yue Ren, Jennifer R Molina, et al.
Cell Chemical Biology|March 11, 2021
A potent and selective PARP14 inhibitor decreases protumor macrophage gene expression and elicits inflammatory responses in tumor explantsLaurie B Schenkel, Jennifer R Molina, Kerren K Swinger, et al.
Cancer Cell|August 10, 2021
PARP7 negatively regulates the type I interferon response in cancer cells and its inhibition triggers antitumor immunityJoseph M Gozgit, Melissa M Vasbinder, Ryan P Abo, et al.
Pageof 1